Lameplast SpA manufactures plastics containers for pharmaceutical and cosmetics products. It provides single dose and multi dose containers, bottles and dispenser. The company was founded by Giovanni Ferrari in 1976 and is headquartered in Rovereto, Italy.

Avance Medical is the first company to develop fully automated systems to produce autologous bio-regenerative fibrin. They process the patient’s own blood during a surgical procedure in the operating room to produce fibrin rich in clotting factors to stop bleeding. The fibrin also has anti-microbial properties especially effective against superbugs like MRSA being the major culprit for hospital-acquired infections. Further, the fibrin contains growth factors vital for regenerating connective tissues and facilitate wound homeostasis and healing. Avance is conducting a number of studies showing promising results in achieving these objectives.

Gattefosse Holding functions as an investment holding company. The company is headquartered in Saint-Priest, France.

Jubilant Generics Ltd. engages in the manufacture and export of pharmaceutical products. The company is headquartered in Greater Noida, India.

SEMCO, Inc. manufactures acoustical panels and silencers. Its products include thermal panel systems enclosures, barrier walls, custom silencers, manifolded duct and energy recovery systems. The company was founded in 1963 and is headquartered in Columbia, MO.

Alaxia is a French private biotech company developing therapeutic solutions for respiratory diseases based on its proprietary peroxidase platform. The most advanced drug candidate, ALX-009, is an antimicrobial innovative compound aiming at treating cystic fibrosis, including the most resistant bacterial strains.

Sofab SA, a subsidiary of Ball Corp., is a French company involved in pumps and pumping equipment. Yves Dominioni is the current CEO, occupying that position since 1995. On December 01, 1994 Rexam Ltd., now part of Ball Corp. acquired Sofab SA from Soci��t�� BIC SA for $104.82 million.

Istituto Farmacologico Serono is a private company headquartered in Rome, Italy, that manufactures and distributes pharmaceutical products.

Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. Its product pipelines include: Biochaperone Lispro, Combo, M1pram, Glucagon, Gla Glp-1, Glucagon Glp-1 & Cell Therapy. The company was founded by Gérard Soula, Olivier Soula and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.

Manufactures pharmaceuticals

Wella Operations US LLC is a multi-national company located in Calabasas, CA. The firm manufactures and sells hair colors. It was founded in 2020. Annie Young-Scrivner is currently the CEO of the company.\nThe company says this about itself: Wella Company is one of the world's leading beauty companies, comprised of a family of iconic brands including Wella Professionals, O·P·I, ghd, Briogeo, Nioxin, Sebastian Professional and Clairol. At Wella Company, we are innovators who seek to inspire consumers and beauty professionals through our brands to look, feel, and be their true selves. We are committed to building the best beauty company in the industry where our 6,000+ employees across more than 100 countries can bring their best selves to work. Guided by our company values and led by purpose to deliver positive impact on people through our products and towards our planet and society, we deliver sustainable growth to all stakeholders.

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

Nichirei Biosciences, Inc. develops, manufactures and distributes immunohistochemistry, diagnostic and cell-biology products. The company was founded on April 01, 2005 and is headquartered in Tokyo, Japan.